Low Dose MSH2-/- tumor cell vaccine
2025-2583
Phase 1 mab active
Quick answer
Low Dose MSH2-/- tumor cell vaccine for pMMR/MSS Advanced Colorectal Cancer is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- pMMR/MSS Advanced Colorectal Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- active